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In human platelet membranes enhanced tyrosine phosphorylation of certain proteins was observed when Zn2+ instead 
of MgZ+ or Mn*+ was used as a divalent cation for the kinase reaction. An enhanced level of phosphate incorporation 
into tyrosine residues occurred into a 68 kDa polypcptide besides the 45 kDa and 105 kDa proteins. Preincubation of 
platelet membranes with TBR-IgG showed a concentration-dependent inhibition of the phosphorylation of the 45. 68 
and 105 kDa proteins. Moreover, pp6oc”c. representing the major protein tyrosine kinase activity in platelets, was found 
to be stimulated by Zn*+. The data, thus, support the assumption that pp6@-‘” kinase is responsible for Zn2+ stimulated 
tyrosine phosphorylation. 
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1. INTRODUCTION 
Protein tyrosine kinase (PTK) activity is 
associated with cellular growth hormone receptors 
and many viral and cellular one gene products, 
suggesting an important role in cell proliferation 
and differentiation [l-5]. High levels of PTK ac- 
tivity have also been found in nonproliferating ter- 
minally differentiated blood cells [6-91. 
In human platelets the major PTK activity has 
been ascribed to pp60’~““, the normal cellular 
homologue of the transforming protein of Rous 
sarcoma virus (RSV), pp60vWsrc [9,10]. However, 
other, as-yet unidentified PTKs may be responsible 
for the extensive tyrosine phosphorylation of 
platelet membrane proteins [6]. 
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Here, we show that tyrosine phosphorylation of 
certain proteins in human platelet membranes is 
strongly enhanced when Zn2+ is used as the only 
divalent cation for the kinase reaction, indicating 
that Zn2+ acts not only as a phosphotyrosyl- 
protein phosphatase inhibitor but also as a 
stimulator of PTK activity. 
2. MATERIALS AND METHODS 
2.1. Materials 
Mops, NasV04, 0-phosphoserine and 0-phosphothreonine 
were obtained from Sigma (Munchen). 0-Phosphotyrosine was 
prepared as in [Ill. [y-32P]ATP (3000 Ci/mmol, 1 Ci = 3.7 x 
10” Bq) was purchased from Amersham Buchler 
(Braunschweig). 
2.2. Membrane isolation 
Platelet-rich plasma (PRP) from healthy volunteers was ob- 
tained 24 h after venipuncture from the local blood bank. PRP 
was centrifuged at 480 x g for 20 min. The sedimented platelets 
were resuspended in a buffer containing 10 mM sodium 
phosphate, 125 mM NaCI, 5 mM KCl, 5 mM EDTA (pH 7.4) 
and washed twice. Membranes from human platelets were 
prepared by three different methods described by Golden et al. 
[9], Waldmann et al. [12] and Resh and Erikson [13]. All buf- 
fers used contained in addition IOOpM NasV04 and 5 mM 
EDTA. The membranes were finally resuspended in 25 mM 
Mops (pH 6.5) and kept frozen until use. 
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2.3. In vitro phosphorylation assay 
The phosphotransferase assay was performed for 20 min at 
4 or 30°C in a total volume of 50 ~1 containing 25 mM Mops 
(pH 6.5), divalent cation and ATP concentrations as indicated 
and 5 pg membrane protein. The reaction was stopped with 
20 ,uI SDS sample buffer and samples analysed by SDS-PAGE 
as described [ 111. The dried gels were exposed to Kodak X- 
Omat films for autoradiography. Desired phosphoproteins 
were cut out from the dried gel and radioactivity determined by 
Cerenkov counting. Activity of pp60c-s’c PTK of human platelet 
membrane xtracts was determined in solid phase according to 
Presek and Reuter [14], modified by incubating together pro- 
tein A-Sepharose, TBR serum and antigenic material (60 ~1) for 
2 h. The phosphotransferase reaction was performed in the 
presence of 25 mM Mops (pH 6.5) instead of Tris buffer. ATP 
and ion concentrations were used as indicated. Membrane ex- 
tracts were prepared by incubating the isolated membranes with 
25 mM Mops (pH 6.5) containing 1% (v/v) Triton X-100 for 
20 min on ice. The material was centrifuged for 15 min at 
30000 x g and the supernatant used in the kinase assay. TBR 
sera (tumor-bearing rabbit sera) were prepared as in [15]. 
2.4. Analysis of phosphoamino acids 
Separation and identification of [32P]phosphoamino acids 
from 32P-labeled proteins were performed according to Hunter 
and Sefton 116). 
2.5. Partial proteolytic peptide analysis 
One-dimensional peptide mapping of the 68 kDa 
phosphoprotein was performed according to Cleveland et al. 
[171. 
2.6. Dephosphorylation assay 
Membrane protein (140/g) was phosphorylated for 30 min 
at 4°C in a total volume of 150 pl containing 25 mM Mops (pH 
6.5), 1 mM MgClz, 1 mM MnC12 and 3 pCi [y-32P]ATP. At the 
end of the incubation period, 200 pl of 1 mM ATP was added 
and the reaction mixture divided into aliquots containing 13 pg 
protein. Some aliquots were directly stopped with 20 ~1 of sam- 
ple buffer as control values. The others were incubated for 
20 min at 30°C in either the absence or presence of PTP in- 
hibitors (200 ,uM NasVO.,, 0.02, 0.1 and 0.5 mM zinc acetate). 
The incubation was terminated with 20 ,uI sample buffer and 
samples analysed on SDS-PAGE. 
3. RESULTS 
Human platelet membranes prepared according 
to three different methods [9,12,13] showed no 
remarkable variations in phosphorylation pattern 
in the presence of Mg’+ and Mn’+. In all further 
experiments, therefore, membranes prepared ac- 
cording to Golden et al. [9] were used. In the 
presence of Mn2+, a drastic increase in phosphate 
incorporation into many proteins was observed as 
compared to Mg2+ (fig.lA). Among these, a 
68 kDa protein was phosphorylated at tyrosine 
residues at 4°C but not at 30°C (fig.1). As a 
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Fig. 1. (A) Divalent cation requirement and temperature 
dependence of tyrosine phosphorylation of membrane proteins. 
Phosphotransferase reactions were performed in the presence 
of 6 nM ATP (3000 Ci/mmol) and various cations for 20 min 
at 4°C (lanes l-5) and 30°C (lanes 6-10). Autoradiograms of 
the “P-labeled phosphoproteins analysed by SDS-PAGE are 
shown. Lanes: 1,6, 1 mM MgCl2; 2,7, 1 mM MnC12; 3,8, 1 mM 
MgClz/l mM MnC12; 4,9, 1 mM MgC12/1 mM MnClz/l mM 
zinc acetate; 5,10, 1 mM zinc acetate (final concentrations). 
(B) Effect of phosphotyrosyl-protein phosphatase inhibitors. 
Platelet membranes were phosphorylated with 1 mM 
MgCl2/MnCl2 and 6 nM ATP in the presence of different 
phosphotyrosyl-protein phosphatase inhibitors for 20 min at 
4°C (lanes l-4) and 30°C (lanes 5-8). Autoradiogram of the 
phosphoprotein patterns is demonstrated. Lanes: 1.5, control; 
2,6, 10 mM NaF; 3,7,200 PM NajV04; 4,8, 1 mM zinc acetate. 
phosphotyrosyl-protein phosphatase (PTP) might 
be responsible for this phenomenon [ 181, we tested 
the effect of the phosphatase inhibitors NaF, 
Na3V04 and Zn2+ upon 68 kDa phosphorylation. 
Only in the presence of Zn2+ (ZnCl2 or zinc 
acetate) did tyrosine phosphorylation of that pro- 
tein occur at 30°C and was enhanced about 3-fold 
at 4°C (fig.lB). Apart from the 68 kDa protein, 
enhancement of tyrosine phosphorylation was 
observed in the 45 kDa and 105 kDa proteins at 
both temperatures. In the case of NaF and 
Na3V04, no change in phosphoprotein patterns 
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Fig.2. Analysis of the phosphorylated 68 kDa membrane protein. Platelet membranes were phosphorylated with 1 mM MgCWl mM 
MnC12 at 4°C (A), 1 mM zinc acetate at 4°C (B) and 1 mM zinc acetate at 30°C (C). Left: one-dimensional phosphoamino acid analysis 
[la]. The dashed circles show the positions of the standard phosphoamino acids identified by ninhydrin. Y, phosphotyrosine; T, 
phosphothreonine; S, phosphoserine; Pi, orthophosphate. Right: partial proteolytic peptide mapping by VS protease. Digestion was 
performed with increasing amounts of Vg protease (Miles Labs). Lanes: 1, 5 ng; 2, SO ng; 3, 500 ng. 
was observed (fig.lB). When prelabeled mem- 
branes were incubated at 30°C in the absence of 
Zn2+ , drastic dephosphorylation of the “P-labeled 
proteins was observed, thus confirming the role of 
Zn2+ in PTP inactivation. Dephosphorylation was 
prevented by 0.5 mM Zn2+, while 20 and 1OOpM 
Zn2+ were without any effect (not shown). 
The enhanced level of phosphate incorporation 
into the 45, 68 and 105 kDa proteins in the 
presence of Zn2+ was specific as none of the other 
divalent cations tested (Sr2+, Pb’+, Nizf, Fe2+, 
0 
Zn+‘concentmtlon (mM1 
cs2+, co2+, Ba’+) induced phosphorylation of 
these proteins. The 68 kDa proteins phos- 
phorylated in the presence of Mg2+/Mn2+ or Zn2+ 
at 4 and at 30°C showed identical phosphopeptide 
patterns after partial proteolysis, indicating that 
the same protein substrate was phosphorylated by 
the kinase independently of the divalent cation 
used. Phosphorylation occurred exclusively at 
tyrosine residues (fig.2). Since Zn2+ also acts as an 
inhibitor of PTP activity, we could study the effect 
of Zn2+ upon phosphorylation of the 68 kDa pro- 
ATP concentration(pM) 
Fig.3. Zn2+ concentration (A) and ATP concentration (B) dependence of 68 kDa protein tyrosine phosphorylation. Experiments were 
performed at 30°C. ATP concentration used in (A) was 2 FM (10 Ci/mmol) and 1 mM zinc acetate was the final divalent cation 
concentration in (B). Enzyme activity is expressed as fmol phosphate incorporated into the 68 kDa protein. 
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tein at 30°C. This was a time-dependent process 
completed within 20 min of incubation time. The 
most effective ion concentration was 1 mM Znzf. 
Higher concentrations of Zn2+ did not stimulate 
PTK activity any further and were even inhibitory 
(fig.3A). The ATP concentration dependence of 
the phosphotransferase reaction gave a saturation 
curve as shown in fig.3B. The K, for ATP was 
0.7 PM. 
Since pp60C-STC is highly active in platelet mem- 
branes [9], we suggest hat the kinase responsible 
for tyrosine phosphorylation of the various pro- 
teins in the presence of Mg2+/Mn2+ and Zn2+ as 
well is pp60c-SrC. In the common kinase assay with 
immobilized pp60’~“” [4,9,11,14,16], we observed 
cation concentration-dependent TBR-IgG 
phosphorylation exclusively at tyrosine residues 
with Zn2+, Mg2+ and Mn2+ (fig.4A). In the 
presence of Zn2+ the kinase was most active using 
10 nM ATP. When higher concentrations of ATP 
were used, Mg2+ was the most stimulating cation 
for pp60C-STC PTK. Surprisingly, Mn2’ and Zn2+ 
had a lower but similar efficiency (fig.4B). Fur- 
thermore, we studied the pp60c-s’c dependence of 
protein phosphorylation in platelet membranes. As 
shown in fig.5, strong inhibition of protein 
phosphorylation was observed in a concentration- 
dependent manner by TBR-IgG but not by control 
IgG. A weak unspecific effect was also evident 
with greater amounts of control IgG only. The 
phosphorylation of the 45, 68 and 105 kDa pro- 
totally blocked by the highest TBR-IgG 
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Fig.5. TBR-IgG-dependent inhibition of protein tyrosine 
phosphorylation in platelet membranes. Membranes were 
incubated for 2 h with different concentrations of TBR-IgG or 
IgG of control serum at 4°C and phosphorylated for 20 min at 
30°C in the presence of 1 mM zinc acetate. Autoradiogram of 
the SDS-polyacrylamide gel is shown: Lanes: I, control (25 mM 
Mops, pH 6.5); 2, control (C)-IgG (0.1 mg/ml); 3, TBR-IgG 
(0.1 mg/ml); 4, C-IgG (0.2 mg/ml); 5, TBR-IgG (0.2 mg/ml); 
6, C-IgG (0.4 mg/ml); 7, TBR-IgG (0.4 mg/ml). Arrow 
indicates the phosphorylated heavy chains of TBR-IgG. 
concentration used. In contrast, phosphorylation 
of the 120 kDa protein was not completely in- 
hibited. This may be due to the activation by Zn2+ 
of another PTK besides pp60c-s’c. 
4. DISCUSSION 
High PTK activity has been reported in ter- 
minally differentiated platelets [6,7,9, lo] which 
resulted in tyrosine phosphorylation of various 
proteins [6,9]. In the presence of Zn2+ as the only 
divalent cation enhanced tyrosine phosphorylation 
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Fig.4. Cation and ATP dependence of pp60c-s’c PTK activity of platelet membranes. 40 pg platelet membrane protein were used in 
the solid-phase assay. (A) Ion concentration dependence was assayed with IO nM ATP (3000 Ci/mmol). (B) ATP concentration 
dependence determined in the presence of 10 mM final concentration of ion. 
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occurred at certain human platelet membrane pro- 
teins (fig.1). Zn2+ has been found to be a potent 
phosphotyrosyl-protein phosphatase (PTP) in- 
hibitor at micromolar concentrations [ 18-231. As 
Zn2+ was able to inhibit dephosphorylation of the 
45, 68 and 105 kDa proteins, we conclude that the 
observed increase in tyrosine phosphorylation by 
Zn2+ is the result of simultaneous PTK activation 
and PTP inhibition. Mn’+, which stimulates PTK 
activity of human platelets [6,7], may have similar 
effects, since it also acts as a PTP inhibitor [24]. 
We found that Zn2+ alone was as effective as Mnzf 
on immunoprecipitated pp60c-“” activity in the 
common solid-phase assay (fig.4). Mg2+ was more 
effective when higher concentrations of ATP were 
used. This may be the reason why Golden et al. [9] 
performed phosphorylation of their platelet mem- 
branes in the presence of 5 mM Mg*+ and 5 PM 
ATP to analyse pp60c~s’C phosphorylation. The 
discrepancy in cation optimum between pp60c-s’c 
TBR-IgG phosphorylation measured in the solid- 
phase assay and 68 kDa protein phosphorylation 
in situ may be caused by an alteration in sensitivity 
of the immobilized enzyme under the solid-phase 
assay conditions. The observed TBR-IgG- 
dependent inhibition of Zn*+-induced membrane 
protein phosphorylation (fig.5) further indicated 
that pp60c-“” is involved in the Zn*+-dependent 
protein phosphorylation. Richard et al. [25] men- 
tioned that the purified degradation product of 
pp60’-s”, ~54, can be activated by Zn*+, but the ef- 
ficiency was only 5% of that obtained with Mg*+. 
The feline sarcoma virus (TPl-FeSV) gag-one fu- 
sion product also exhibited autophosphorylation 
at tyrosine residues in the presence of Zn*+ [26]. 
Zn*+, on the other hand, had no effect on the ac- 
tivity of an unidentified PTK of HL 60 cells [27]. 
Inhibition of PTK activity by Zn*+ was reported 
for tyrosine phosphorylation of the epidermal 
growth factor receptor [28] and autophosphoryla- 
tion of the insulin receptor which was completely 
blocked by 10 PM Zn*+ [29]. In contrast, Avruch 
et al. [30] could not demonstrate an inhibitory ef- 
fect of Zn*+ upon insulin receptor tyrosine 
phosphorylation. 
A sequence within the catalytic domain of 
pp60c-s’c [ 11, Cys(487)-&-His-X3-Cys-X-Cys [3 11, 
is similar to one of those reported in nucleic acid 
binding proteins which potentially could form 
metal-binding domains [32]. Lys 295 which forms 
part of the ATP-binding site of pp60c-s’c [l] is not 
present within this sequence, but the binding of 
Zn*+ to pp60c-“‘C may lead to a conformational 
change in the molecule resulting in enhanced PTK 
activity. A similar mechanism has been discussed 
for PKC activation by Zn*+ [33]. Our results in- 
dicate that ZnZC can activate pp60cYsrc and may be 
an efficient tool for detecting unknown protein 
substrates of PTKs in vitro. The physiological 
significance of Zn*+-dependent PTK activation in 
intact platelets, however, remains unknown and 
may be an interesting subject for further in- 
vestigation. 
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